Evotec, Dow AgroSciences Enter Proteomics Service Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Evotec today announced a collaboration to support the development of compounds in development at Dow AgroSciences.

As part of the deal, Evotec will provide its quantitative chemical proteomics services to "de-convolute phenotypic screening results" obtained by Dow AgroSciences, a wholly owned subsidiary of Dow Chemical.

Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.